Literature DB >> 20402789

Effect of trace iron levels and iron withdrawal by chelation on the growth of Candida albicans and Candida vini.

Bruce E Holbein1, Ramón Mira de Orduña.   

Abstract

The iron requirements of the opportunistic pathogenic yeast, Candida albicans, and the related nonpathogenic spoilage yeast Candida vini were investigated along with their responses to various exogenous iron chelators. The influence of iron as well as the exogenous chelating agents lactoferrin, EDTA, deferiprone, desferrioxamine, bathophenanthroline sulphonate and a novel carried chelator with a hydroxypyridinone-like Fe-ligand functionality, DIBI, on fungal growth was studied in a chemically defined medium deferrated to trace iron levels (<1.2 microg L(-1) or 0.02 microM of Fe). Candida albicans competed better at low iron levels compared with C. vini, which was also more susceptible to most added chelators. Candida albicans was resistant to lactoferrin at physiologically relevant concentrations, but was inhibited by low concentrations of DIBI. Candida vini was sensitive to lactoferrin as well as to DIBI, whose inhibitory activity was shown to be Fe reversible. The pathogenic potential of C. albicans and the nonpathogenic nature of C. vini were consistent with their differing abilities to grow under iron-limiting conditions and in the presence of exogenous iron chelators. Both yeasts could be controlled by appropriately strong chelators. This work provides the first evidence of the iron requirements of the spoilage organism C. vini and its response to exogenous chelators. Efficient iron withdrawal has the potential to provide the basis for new fungal growth control strategies.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20402789     DOI: 10.1111/j.1574-6968.2010.01956.x

Source DB:  PubMed          Journal:  FEMS Microbiol Lett        ISSN: 0378-1097            Impact factor:   2.742


  8 in total

1.  Functional characterization of the ferroxidase, permease high-affinity iron transport complex from Candida albicans.

Authors:  Lynn Ziegler; Alaina Terzulli; Ruchi Gaur; Ryan McCarthy; Daniel J Kosman
Journal:  Mol Microbiol       Date:  2011-06-07       Impact factor: 3.501

2.  DIBI, a 3-hydroxypyridin-4-one chelator iron-binding polymer with enhanced antimicrobial activity.

Authors:  M Trisha C Ang; Roger Gumbau-Brisa; David S Allan; Robert McDonald; Michael J Ferguson; Bruce E Holbein; Matthias Bierenstiel
Journal:  Medchemcomm       Date:  2018-06-18       Impact factor: 3.597

3.  Iron Restriction to Clinical Isolates of Candida albicans by the Novel Chelator DIBI Inhibits Growth and Increases Sensitivity to Azoles In Vitro and In Vivo in a Murine Model of Experimental Vaginitis.

Authors:  Kimberley A Savage; Maria del Carmen Parquet; David S Allan; Ross J Davidson; Bruce E Holbein; Elizabeth A Lilly; Paul L Fidel
Journal:  Antimicrob Agents Chemother       Date:  2018-07-27       Impact factor: 5.191

4.  Enhanced Fe3+ binding through cooperativity of 3-hydroxypyridin-4-one groups within a linear co-polymer: wrapping effect leading to superior antimicrobial activity.

Authors:  Roger Gumbau-Brisa; M Trisha C Ang; Bruce E Holbein; Matthias Bierenstiel
Journal:  Biometals       Date:  2020-10-19       Impact factor: 2.949

Review 5.  The utility of iron chelators in the management of inflammatory disorders.

Authors:  C Lehmann; S Islam; S Jarosch; J Zhou; D Hoskin; A Greenshields; N Al-Banna; N Sharawy; A Sczcesniak; M Kelly; K Wafa; W Cheliak; B Holbein
Journal:  Mediators Inflamm       Date:  2015-03-23       Impact factor: 4.711

6.  Novel Iron-Chelator DIBI Inhibits Staphylococcus aureus Growth, Suppresses Experimental MRSA Infection in Mice and Enhances the Activities of Diverse Antibiotics in vitro.

Authors:  Maria Del Carmen Parquet; Kimberley A Savage; David S Allan; Ross J Davidson; Bruce E Holbein
Journal:  Front Microbiol       Date:  2018-08-14       Impact factor: 5.640

7.  Comparison of Treatment Effects of Different Iron Chelators in Experimental Models of Sepsis.

Authors:  Christian Lehmann; Maral Aali; Juan Zhou; Bruce Holbein
Journal:  Life (Basel)       Date:  2021-01-14

8.  Investigation of the biological properties of (hetero)aromatic thiosemicarbazones.

Authors:  Maciej Serda; Anna Mrozek-Wilczkiewicz; Josef Jampilek; Matus Pesko; Katarina Kralova; Marcela Vejsova; Robert Musiol; Alicja Ratuszna; Jaroslaw Polanski
Journal:  Molecules       Date:  2012-11-14       Impact factor: 4.411

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.